Skip to content

Use of mechanical insufflation-exsufflation for ineffective cough in diseases of the peripheral or central nervous system

Use of mechanical insufflation-exsufflation for ineffective cough in diseases of the peripheral or central nervous system - MEDINE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00020981
Enrollment
100
Registered
2021-02-11
Start date
2022-10-17
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G62.80 I63

Interventions

Group 1: mechanical insufflator-exsufflator Group 2: standard management of tracheobronchial secretions

Sponsors

Koninklijke Philips N.V.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Existent severe illness from the neurological or neurosurgical spectrum defined as early rehabilitation Barthel Index (ERBI) 7 or cough >1 on ACS (Coplin et al. 2000, Windisch et al. 2017, Tanwar et al. 2019)

Exclusion criteria

Exclusion criteria: Age <18 years, known bullous pulmonary emphysema, presence of pneumothorax during current clinical treatment or instable sternum. Amyotrophic lateral sclerosis as well as other progressive neuromuscular disorders and paraplegia, continous intracenous sedation, orally intubated patients, expected death on the ICU

Design outcomes

Primary

MeasureTime frame
Duration of mechanical ventilation

Secondary

MeasureTime frame
incidence of ventilator associated pneumonia

Countries

Germany

Contacts

Public ContactMartin Groß

Evangelisches Krankenhaus OldenburgKlinik für Neurologische Intensivmedizin und Frührehabilitation

martin.gross@evangelischeskrankenhaus.de0441236387

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026